Biosimilar Newsletter Archive

1. 08.28.25 -- The Building Blocks Of A Robust Analytical Assay 8/28/2025
   08/28/25 Biosimilar Development Newsletter
2. 08.21.25 -- Production Of A Highly Concentrated mAb 8/21/2025
   08/21/25 Biosimilar Development Newsletter
3. 08.14.25 -- Preparing For FDA's Expanded Use Of Unannounced Inspections At Foreign Facilities 8/14/2025
   08/14/25 Biosimilar Development Newsletter
4. 08.07.25 -- Unlocking Value In Biopharma Operations: A C-Suite Call To Action 8/7/2025
   08/07/25 Biosimilar Development Newsletter
5. 07.31.25 -- Navigating FDA Regulatory Changes 7/31/2025
   07/31/25 Biosimilar Development Newsletter
6. 07.25.25 -- Tools For Smarter Antibody Discovery 7/25/2025

   07/25/25 Biosimilar Development Newsletter

7. 07.17.25 -- Bracing For The Impact Of The Federal Workforce Reduction 7/17/2025
   07/17/25 Biosimilar Development Newsletter
8. 07.16.25 -- Helpful Biosafety Testing Innovations For mAbs Development And Manufacturing 7/16/2025

   07/16/25 Biosimilar Development Newsletter

9. 07.13.25 -- Transitioning From Research To Commercialization: A Roadmap 7/13/2025
   07/13/25
10. 07.10.25 -- Take a look at our useful PUPSIT overview and implementation resources. 7/10/2025

    07/10/25 Biosimilar Development Newsletter